Our News and Events page is the best way to stay up-to-date with PoCoG news and to learn about upcoming opportunities.

07/02/2018 - Invitation to participate in a Delphi study on clinical FCR

PoCoG members are invited to participate in a study on clinical fear of cancer recurrence (FCR) in order to reach expert consensus on the defining features of clinical FCR.

The researchers expect expect there will be three iterations of the Delphi process where participants will rate and suggest characteristics of clinical FCR. Each round of the Delphi will take approximately 15-30 minutes to complete, and participants will have two weeks to complete each round.


The inclusion criteria for this International Delphi Study on Clinical FCR are:

  1. Participants must be: researchers (who have published a peer-reviewed article on the subject of FCR within the last 5 years), or nurses, social workers, physicians, psychologists, or other health professionals (with at least 5 years of experience working with cancer survivors)
  2. Must work with cancer survivors
  3. Must be able to read and write in English
  4. Have access to a computer with an internet connection
  5. Must have an email address in order to received Rounds 2 and 3 of the Delphi study questionnaires

Please click the link below to the first questionnaire of the Delphi study. In order to send participants the Delphi questionnaires for the second and third rounds,you will be asked to provide an email address.


Completed questionnaires should be submitted by 1 March 2018.

The ethical aspects of this study have been approved by the University of Ottawa Research Ethics Board.

If you have any questions, please contact Brittany Mutsaers ( or Dr. Sophie Lebel (


On behalf of Dr. Phyllis Butow, Dr. Andreas Dinkel, Dr. Gerald Humphris, Dr. Christine Maheu,      Dr. Gozde Ozakinci, Dr. Judith Prins, Dr. Louise Sharpe, Dr. Allan ‘Ben’ Smith, and Dr. Belinda Thewes

Please feel free to pass along this recruitment email to anyone you think may be interested in participating, and who is currently conducting research on FCR or who is a clinician with experience with FCR.
Return to Previous Page